Tag: Crohn’s Disease
Study Compares Surgical Techniques for Crohn Disease
Longest length of stay, increased odds of wound complications seen for small bowel resection versus strictureplasty and combined approach
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
Risankizumab noninferior for clinical remission at week 24, superior for endoscopic remission at week 48
Top-Down Treatment Superior for Crohn Disease
One-year outcomes better with early combined infliximab + immunomodulator vs. accelerated step-up treatment
Higher Use of Any Rx Medications Seen Years Before IBD Diagnosis
Findings strongest for Crohn disease with ties to multisystem organ involvement
Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease
Odds for Crohn disease and ulcerative colitis increased with higher serum perfluoroalkyl and polyfluoroalkyl substance levels up to 10 years before diagnosis
Histologic Inflammation With IBD Tied to Serious Infections
Authors say achieving histologic remission for both Crohn disease and ulcerative colitis may reduce the risk for serious infections
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
Findings seen for inflammatory bowel disease overall, as well as individual diseases
COVID-19 May Raise Risk for Immune Disorders like Alopecia and Crohn’s, New Study Finds
A new study suggests people with a history of COVID-19 may face increased odds for autoimmune and autoinflammatory disorders, including alopecia, Crohn’s disease and vasculitis.
COVID-19 podría aumentar el riesgo de trastornos inmunológicos como alopecia y enfermedad de Crohn,...
Un nuevo estudio sugiere que las personas con antecedentes de COVID-19 podrían enfrentar mayores probabilidades de padecer trastornos autoinmunes y autoinflamatorios, incluida la alopecia, la enfermedad de Crohn y la vasculitis.
AI-Based Radiomic Model Improves Diagnosis of Crohn Disease
Model performance improved with combination of radiological, clinical data
